Carl Icahn

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) initiated layoffs within its research and development (R&D) team, affecting approximately 10% of that staff. These layoffs began late last Wednesday and impacted research teams at various locations, including San Diego and Foster...

Icahn Enterprises L.P. (NASDAQ: IEP), the holding company owned by billionaire investor Carl Icahn, experienced another bloodbath on Thursday, plummeting 21% after dropping by 13% the day before, and on track for the worst session of its history.  This comes after Icahn's...

Pershing Square Capital Management founder and CEO Bill Ackman weighed in on billionaire Carl Icahn and his company following the release of a short report by Hindenburg Research. Ackman commented that there were some interesting takeaways from the situation that...

Prominent activist investor Carl Icahn has acknowledged his error in placing a substantial bet on a market crash, ultimately resulting in his group suffering losses of nearly $9 billion over six years. The net asset value of Icahn Enterprises LP (NASDAQ: IEP) decreased from $7.9...

Editor's note: This story has been updated to reflect that Carl Icahn's stock purchases in the first quarter of 2023 came before the publication of Hindenburg Research's short report.  Billionaire activist investor Carl Icahn faced a steep challenge recently as his conglomerate,...

Short-seller Hindenburg Research continues to scrutinize the business practices of Carl Icahn and his namesake conglomerate, Icahn Enterprises LP (NASDAQ: IEP). What Happened: After publishing a bearish report last week accusing Icahn of mismanagement, Hindenburg — under the...

Icahn Enterprises LP (NASDAQ: IEP) responded strongly to a short-seller report by Hindenburg Research that accused the investment firm's founder, Carl Icahn, of mismanagement. What Happened: Hindenburg's report alleged that IEP operated a Ponzi-like scheme, utilizing funds from new...

Icahn Enterprises L.P. (NASDAQ: IEP) shares had their worst trading day since October 2002, falling almost 20% on Tuesday following the release of an extremely negative report by short seller Hindenberg Research. Hindenburg Research alleged in a study titled "Icahn...

GameStop Corp. (NYSE: GME) shares were up another 1.6% on Wednesday following reports that billionaire investor Carl Icahn is still short-selling the stock. Entering 2021 GameStop was one of the most heavily shorted stocks in the market, but short interest in the video game retailer has declined...

Longtime activist investor Carl Icahn is still shorting GameStop Corp (NYSE: GME) and has been since early 2021. Confirmed short-seller reports would previously send the retail investor-backed stock soaring, but GameStop shares are barely budging Tuesday (Nov. 22), which begs the...

Legendary investor Carl Icahn said Thursday’s Wall Street rally did not change his negative view on the market, and he believes a recession is still lurking on the horizon, according to a CNBC report. “We keep our portfolio hedged. I am still very, quite...

Back in 2021, reports surfaced that famed investor Carl Icahn held a roughly $400-million stake — around 1.2% — in Illinois-based insurer Allstate Corp (NYSE: ALL). Citing people familiar with the matter, the Wall Street Journal reported in May 2021 the billionaire...

Activist investor Ryan Cohen is a person who can move the markets with a tweet. A tweet from Cohen on Monday night has investors speculating on what could be coming for GameStop Corporation (NYSE: GME), a company that counts Cohen as an investor and the chairman. What Happened: On Monday, Oct. 17...

Corvex Management was founded in 2011 by Carl Icahn’s former right-hand man Keith Meister, and saw its assets double by 2013. Activist investor Meister used Icahn’s philosophy of being contrarian and aggressive and he received $1 billion in seed capital from George Soros...

Bed Bath & Beyond Inc (NASDAQ: BBBY) shares hit 52-week lows on Wednesday after the company reported weak earnings results and announced a CEO transition. One analyst believes the pain is just getting started. What Happened: Bed Bath & Beyond's worse-than-expected results didn...